BridgeBio Pharma (BBIO) Total Assets (Quarterly): 2.162B

BridgeBio Pharma, Inc. (BBIO)

78.17 -1.37 (-1.72%) USD | NASDAQ | Nov 12, 16:00

78.40 +0.23 (+0.29%) After-Hours: 07:32

Total Assets (Quarterly) Chart

Historical Total Assets (Quarterly) Data

View and export this data back to 2018. Start Trial.

Date	Value
September 30, 2026	2.162B
June 30, 2026	1.217B
March 31, 2026	1.371B
December 31, 2025	936.02M
September 30, 2025	998.25M
June 30, 2025	1.080B
March 31, 2025	881.64M
December 31, 2024	919.34M
September 30, 2024	664.98M
June 30, 2024	794.38M
March 31, 2024	849.33M
December 31, 2023	546.38M
September 30, 2023	655.01M
June 30, 2023	503.66M
March 31, 2023	625.68M
December 31, 2022	623.04M

Date	Value
September 30, 2022	728.74M
June 30, 2022	862.23M
March 31, 2022	813.15M
December 31, 2021	1.013B
September 30, 2021	781.52M
June 30, 2021	1.081B
March 31, 2021	1.093B
December 31, 2020	703.59M
September 30, 2020	787.69M
June 30, 2020	905.23M
March 31, 2020	989.80M
December 31, 2019	631.68M
September 30, 2019	640.53M
June 30, 2019	325.54M
March 31, 2019	401.37M
December 31, 2018	464.94M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks